Patents by Inventor Mario Stegert

Mario Stegert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240301053
    Abstract: Combination therapies comprising TIM-3 inhibitors are disclosed. The combinations can be used to treat cancerous conditions and disorders, including hematologic cancers.
    Type: Application
    Filed: October 20, 2020
    Publication date: September 12, 2024
    Inventors: Hans Menssen, Pedro Miguel Da Silva Cecilio Marques Ramos, Mario Stegert
  • Publication number: 20140221389
    Abstract: The present invention relates to a method of treating a cancer in patient in need thereof by administering 4-amino-5 fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one, or a tautomer thereof, or a salt of any one of them, wherein the patient is a moderate hepatic impaired patient.
    Type: Application
    Filed: September 7, 2012
    Publication date: August 7, 2014
    Applicant: Novartis AG
    Inventors: Suraj Anand, Catherine Reddick, Michael Shi, Mary Steed, Mario Stegert, Eugene Tan, Yongyu Wang
  • Publication number: 20060172374
    Abstract: The present invention relates to the phosphorylated form of nuclear serine/threonine protein kinase, designated nuclear, Dbf2-related kinase (Ndr), and provides assays and materials for identifying modulators thereof. The invention relates to the fields of molecular biology, chemistry, pharmacology, and screening technology.
    Type: Application
    Filed: November 25, 2003
    Publication date: August 3, 2006
    Inventors: Samuel Bichsel, Brian Hemmings, Mario Stegert, Rastislav Tamaskovic